News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why Young Scientists Ditch Postdocs For Biotech Startups



11/16/2016 1:03:41 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Vindication was three years coming for Ethan Perlstein. On 19 October, his California biotechnology company, Perlara, announced a deal with Novartis. The Swiss drug giant will test a compound that Perlara has identified as a possible treatment for a rare childhood disease, and will invest an undisclosed sum in the smaller firm.

Numerous biotech investors turned Perlstein away before he started Perlara in San Francisco in 2014, because he wasn’t the tenured professor that most venture capitalists saw as founder material. “They pretty much told me to take a hike,” he recalls.

Read at Nature


comments powered by Disqus
Nature
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES